Genomic HLA profiles of MS in Hokkaido, Japan: Important role of DPB1*0501 allele

Journal of Neurology

Volumn 247, Issue 3, 2000, Pages 175-178

  Fukazawa, T ^a   Kikuchi, S ^b   Sasaki, H ^b   Yabe, I ^b   Miyagishi, R ^b   Hamada, T ^a   Tashiro, K ^b  

^a Hokuyukai Neurology Hospital   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

HLA class II; HLA DPB I; HLA DQB I; Japanese; Multiple sclerosis

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DP ANTIGEN; HLA DQ ANTIGEN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

EID: 0034112152     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004150050558     Document Type: Article

References (26)

1. 1. Batchelor JR, Compston A, McDonald WI (1978) The significance of the association between HLA and multiple sclerosis. Br Med Bull 34:279-284
2. 2. Blakiston TW (1883) Japan in Yezo, with itineraies of distances on travelled routes, and a sketch map of Yezo. Japan Gazette Office, Yokohama, pp 38-42
3. 3. Buyse I, Decorte R, Baens M, Cuppens H, Semana G, Emonds M-P, Marynen P, Cassiman J-J (1993) Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse dot blot hybridization. Tissue Antigens 41:1-14
4. 4. Compston DAS, Kellar Wood H, Robertson N, Sawcer S, Wood NW (1995) Genes and susceptibility to multiple sclerosis. Acta Neurol Scand Suppl 161:43-51
5. 5. Dekker JW, Easteal S, Jakobsen IB, Gao X, Stewart GJ, Buhler MM, Hawkins BR, Higgins DA, Yu YL, Serjeantson SW (1992) HLA-DPB1 alleles correlate with risk for multiple sclerosis in Caucasoid and Cantonese patients lacking the high-risk DQB1 *0602 allele. Tissue Antigens 41:31-36
6. 6. Fazekas F, Offenbacher H, Schmidt R, Strasser-Fuchs S (1994) MRI of neuromyelitis optica: evidence for a distinct entity. J Neurol Neurosurg Psychiatry 57:1140-1142
7. 7. Fukazawa T, Hamada T, Tashiro K, Moriwaka F, Yanagihara T, Sugiyama K, Tsukada Y (1992) HLA profiles of multiple sclerosis in Hokkaido, the northernmost island of Japan. Acta Neurol Scand 86:517-520
8. 8. Fukazawa T, Tashiro K, Hamada T, Moriwaka F, Matsumoto A, Shima K, Maruo Y (1992) Multiple sclerosis in Hokkaido, the northernmost island of Japan: prospective analyses of clinical features. Intern Med 31:349-352
9. 9. Fukazawa T, Hamada T, Tashiro K, Moriwaka F, Yanagihara T (1990) Acute transverse myelopathy in multiple sclerosis. J Neurol Sci 100:217-222
10. 10. Fukazawa T, Miyasaka K, Tashiro K, Hamada T, Moriwaka F, Yanagihara T, Hamada K (1992) MRI findings of multiple sclerosis with acute transverse myelopathy. J Neurol Sci 110:27-31
11. 11. Fukazawa T, Hamada T, Moriwaka F, Tashiro K (1994) Acute transverse myelopathy in MS: clinical considerations. Int MS J 1:26-33
12. 12. Fukazawa T, Moriwaka F, Mukai M, Hamada T, Koike T, Tashiro K (1993) Anticardiolipin antibodies in Japanese patients with multiple sclerosis. Acta Neurol Scand 88:184-189
13. 13. Fukazawa T, Hamada T, Kikuchi S, Sasaki H, Tashiro K (1996) Antineutrophil cytoplasmic antibodies and the optic-spinal cord of multiple sclerosis in Japan. J Neurol Neurosurg Psychiatry 61:203-204
14. 14. Fukazawa T, Kikuchi S, Sasaki H, Hamada K, Hamada T, Miyasaka K, Tashiro K (1997) Anti-nuclear antibodies and the optic spinal form of multiple sclerosis. J Neurol 244:483-488
15. 15. Hao Q, Saida T, Kawakami H, Mine H, Maruya E, Inoko H, Saji H (1992) HLAs and genes in Japanese patients with multiple sclerosis: evidence for increased frequencies of HLA-CW3, HLA-DR2, and HLA-DQB1 *0602. Hum Immunol 35:116-124
16. 16. Hillert J (1994) Human leukocyte antigen studies in multiple sclerosis. Ann Neurol 36:S15-S17
17. 17. Ito H, Yamasaki K, Kawano Y, Horiuchi I, Yun C, Nishimura Y, Kira J (1998) HLA-DP-associated susceptibility to the optic-spinal form of multiple sclerosis in the Japanese. Tissue Antigens 52:179-182
18. 18. Kira J, Kanai T, Nishimuta Y, Yamasaki K, Matsushita S, Kawano Y, Hasuo K, Tobimatsu S, Kobayashi T (1996) Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 40:569-574
19. 19. Mandler RN, Davis LE, Jeffery DR, Kornfeld M (1993) Devic' s neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 34: 162-168
20. 20. Ødem N, Saida T, Ohta M, Svejgaad A (1989) HLA-DP antigens and HTLV-1 antibody studies among Japanese with multiple sclerosis: evidence for an increased frequency of HLA-DPw4. J Immunogen 16:467-473
21. 21. Oksenberg JR (1996) Immunogenetics and heterogeneity in multiple sclerosis. Ann Neurol 40:557-558
22. 22. O'Riordan JI, Gallagher HL, Thompson AJ, Howard RS, Kingsley DPE, Thompson EJ, McDonald WI, Miller DH (1996) Clinical, CSF, and MRI findings in Devic' s neuromyelitis optica. J Neurol Neurosurg Psychiatry 60: 382-387
23. 23. Poser CM, Paty DW, Schinberg L, McDonald DI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-231
24. 24. Shibasaki H, McDonald WI, Kuroiwa Y (1981) Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 49:253-271
25. 25. Tiwari JL, Terasaki PI (1985) Multiple sclerosis. In: Tiwari JL, Terasaki PI (eds) HLA and disease associations. Springer, Berlin Heidelberg New York, pp 152-167
26. 26. Vernant J-C, Cabre P, Smadja D, Merle H, Caubarrére I, Mikol J, Poser CM (1997) Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 48:58-64